Periglaucine A is primarily studied for its potential biological activity, particularly in the field of cancer research. It has shown cytotoxic effects against certain tumor cell lines, making it a subject of interest in the development of anticancer agents. Its mechanism may involve interference with cell division or induction of apoptosis in malignant cells. Additionally, Periglaucine A has been investigated for its anti-inflammatory and immunomodulatory properties, suggesting possible use in treating chronic inflammatory conditions. Due to its natural origin and structural complexity, it also serves as a lead compound for the synthesis of derivatives with enhanced therapeutic profiles. Research remains in the preclinical stage, focusing on understanding its efficacy, safety, and mode of action.